Evolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)

Evolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)

Cleveland Clinic Cancer Advances · 2025-05-15

Brian T. Hill, MD, PhD, Director of the Lymphoid Malignancies Program at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the latest updates in first-line therapy for chronic lymphocytic leukemia (CLL). During this episode, Dr. Hill explains the shift from traditional chemoimmunotherapy to more precise, targeted treatments, and how customized therapy is transforming patient outcomes.

Cleveland Clinic Cancer Advances

A Cleveland Clinic podcast for medical professionals exploring the latest innovative research and clinical advances in the field of oncology.

Where can you listen?

Apple Podcasts Logo Spotify Logo Podtail Logo Google Podcasts Logo RSS

Episodes